National Research Corporation (NRC)
- Previous Close
32.87 - Open
32.67 - Bid 33.53 x 100
- Ask 34.00 x 100
- Day's Range
32.08 - 34.37 - 52 Week Range
32.08 - 47.25 - Volume
36,160 - Avg. Volume
61,224 - Market Cap (intraday)
803.634M - Beta (5Y Monthly) 0.43
- PE Ratio (TTM)
26.93 - EPS (TTM)
1.25 - Earnings Date Apr 30, 2024 - May 6, 2024
- Forward Dividend & Yield 0.48 (1.46%)
- Ex-Dividend Date Mar 27, 2024
- 1y Target Est
--
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty. The company also offers marketing solutions that allow the tracking of awareness, perception, and consistency of healthcare brands; assessment of competitive differentiators; and enhanced segmentation tools to evaluate needs, wants, and behaviors of communities through real-time competitive assessments and enhanced segmentation tools. In addition, it provides experience solutions, such as patient experience, employee engagement, health risk assessments, care transition, and improvement tools. Further, the company provides reputation solutions that allow healthcare organizations to share a picture of their organization and ensure that timely and relevant content informs consumer decision-making; and governance solutions for not-for-profit hospital and health system boards of directors, executives, and physician leadership. National Research Corporation was founded in 1981 and is headquartered in Lincoln, Nebraska.
www.nrchealth.com435
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: NRC
Performance Overview: NRC
Trailing total returns as of 4/19/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: NRC
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: NRC
Valuation Measures
Market Cap
784.10M
Enterprise Value
814.13M
Trailing P/E
26.30
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
5.46
Price/Book (mrq)
16.02
Enterprise Value/Revenue
5.48
Enterprise Value/EBITDA
17.42
Financial Highlights
Profitability and Income Statement
Profit Margin
20.84%
Return on Assets (ttm)
19.81%
Return on Equity (ttm)
51.20%
Revenue (ttm)
148.58M
Net Income Avi to Common (ttm)
30.96M
Diluted EPS (ttm)
1.25
Balance Sheet and Cash Flow
Total Cash (mrq)
6.65M
Total Debt/Equity (mrq)
79.57%
Levered Free Cash Flow (ttm)
16.85M
Research Analysis: NRC
Fair Value
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell